Guevarra, Rodialo E.

HRN: 04-44-10  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2023
CEFUROXIME 1.5GM (VIAL)
02/28/2023
03/07/2023
IV
1.5GMS
Q8h
Open Fracture
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: